recent studies with oral flecainide therapy suggested its high potential for suppression of ventricular tachycardia in humans ( anderson et al. , 1981 ; duff et al. , 1981 ; hodges et al. , 1982 ) .
C0016229
flecainide
C0042514
ventricular tachycardia